D

Duality Biotherapeutics Inc
HKEX:9606

Watchlist Manager
Duality Biotherapeutics Inc
HKEX:9606
Watchlist
Price: 322.6 HKD 4.74%
Market Cap: 28.7B HKD

Wall Street
Price Targets

Price Targets Summary
Duality Biotherapeutics Inc

Wall Street analysts forecast Duality Biotherapeutics Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Duality Biotherapeutics Inc is 456.96 HKD with a low forecast of 370.73 HKD and a high forecast of 573.95 HKD.

Lowest
Price Target
370.73 HKD
15% Upside
Average
Price Target
456.96 HKD
42% Upside
Highest
Price Target
573.95 HKD
78% Upside
Duality Biotherapeutics Inc Competitors:
Price Targets
207940
Samsung Biologics Co Ltd
35% Upside
CAPR
Capricor Therapeutics Inc
49% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
10% Upside
196170
Alteogen Inc
20% Upside
600201
Jinyu Bio-Technology Co Ltd
40% Downside
002252
Shanghai RAAS Blood Products Co Ltd
12% Upside
TXG
10X Genomics Inc
5% Upside
2269
WuXi Biologics (Cayman) Inc
21% Upside

Revenue
Forecast

Revenue Estimate
Duality Biotherapeutics Inc

The compound annual growth rate of Duality Biotherapeutics Inc's revenue for the next 4 years is 8%.

N/A
Past Growth
8%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Duality Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Duality Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Duality Biotherapeutics Inc's stock price target?
Price Target
456.96 HKD

According to Wall Street analysts, the average 1-year price target for Duality Biotherapeutics Inc is 456.96 HKD with a low forecast of 370.73 HKD and a high forecast of 573.95 HKD.

What is Duality Biotherapeutics Inc's Revenue forecast?
Projected CAGR
8%

The compound annual growth rate of Duality Biotherapeutics Inc's revenue for the next 4 years is 8%.

Back to Top